Sign In
Buy GNOM
$49.01
+0.96 (+1.99%)
At Close: Jun 03, 2026
Genomics ETF (GNOM) Hits New 52-Week High
12:00am, Tuesday, 26'th May 2020
Stocks Analysis by Zacks Investment Research covering: . Read Zacks Investment Research's latest article on Investing.com
The Next Big Theme: April 2020
04:38am, Thursday, 09'th Apr 2020
The coronavirus outbreak has millions of people around the world working remotely. As a result, the demand for cloud computing is surging.
8 Small Biotech ETFs for Investors | Investing News Network
02:55am, Tuesday, 10'th Mar 2020
Want to invest in small biotech ETFs? Here we profile eight that life science investors may want to look into.
What is Genetics Investing? | Investing News Network
05:00am, Thursday, 27'th Feb 2020
Genetics investing drives research that may ultimately prevent major illnesses. That makes it one of the most important life science fields.
A Decade Of Change: How Tech Evolved In The 2010s And What's In Store For The 2020s
10:55am, Sunday, 16'th Feb 2020
Significant technological advancements and societal shifts occurred during the 2010's decade. Over this next decade, the 2020s, we expect similar rapid and mean
Will These Tech Stock Valuations Last?
01:06pm, Thursday, 13'th Feb 2020
Despite the coronavirus concerns that have hit commodity markets and, in turn, energy and basic materials stocks, U.S. tech stocks have posted strong returns to
Should Investors Avoid U.S. Healthcare Stocks In An Election Year?
02:35pm, Monday, 10'th Feb 2020
US healthcare is always a political hot potato, and volatility is expected to rise as the November elections approach. The US healthcare sector traded at a pric
EQRx's Challenge, And My Challenge To Them
01:15pm, Thursday, 16'th Jan 2020
EQRx's plan is apparently to come up with new competing pharmaceuticals in existing categories and sell them for lower prices than the patented ones. Insurance
Why This Thematic Healthcare Could be a January Winner
04:13pm, Thursday, 09'th Jan 2020
Due in large part to the J.P. Morgan Health Care conference in San Francisco, the biotechnology industry’s marquee yearly confab, January is often a strong month for related equities and ETFs. That
4 Sector ETFs That Beat the Market in Q4
07:30pm, Thursday, 26'th Dec 2019
While Wall Street is surging this quarter, these sector ETFs offered even better performances to beat the market.
Best & Worst Monthly Performers: December 18 Edition
06:41pm, Wednesday, 18'th Dec 2019
Here is a look at the 25 best and 25 worst ETFs from the past week. Traders can use this list to find prospective candidates that have deviated too far from their longer-term trends, thereby serving a
Beyond Biotech, 5 ETFs Up At Least 10% in Q4
01:00pm, Thursday, 12'th Dec 2019
Apart from biotech, these ETFs are seeing solid momentum in the ongoing quarter.
Hedge Funds Have Never Been This Bullish On PTC Therapeutics, Inc. (PTCT)
03:23am, Thursday, 05'th Dec 2019
We are still in an overall bull market and many stocks that smart money investors were piling into surged through the end of November. Among them, Facebook and Microsoft ranked among the top 3 picks a
Biotech Tops in November: Best ETFs & Stocks
05:15pm, Friday, 29'th Nov 2019
The biotech space of the broad healthcare sector outperformed others in November, courtesy of a series of positive news including study results, regulatory backdrop and deal activities.
Genomics ETFs Surge on CRISPR's Gene Editing Progress
11:55pm, Monday, 25'th Nov 2019
The release of encouraging data on the CRISPR/Cas9 gene-editing therapy CTX001 for two severe blood disorders puts emphasis on some genomic ETFs.
